A researcher in Purdue University’s College of Science, USA, is developing a patent-pending platform technology that mimics the dual-layer structure...
Vous n'êtes pas connecté
In a significant breakthrough for the field of genomics, a leading researcher based at the University of Geneva, Egyptian scientist Haitham Shaaban, has unveiled new insights into the genetic origins of cancer and aging. Shaaban is a specialist in developing digital microscopy to monitor the instantaneous interactions of genetic material within cells. This aligns with …
A researcher in Purdue University’s College of Science, USA, is developing a patent-pending platform technology that mimics the dual-layer structure...
Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease. A new...
For hydrogen technology to become a key to the energy transition, it needs to take a decisive step forward toward broad application. The main factors...
For hydrogen technology to become a key to the energy transition, it needs to take a decisive step forward toward broad application. The main factors...
GENEVA, Switzerland – With the support of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), the World Health Organization...
Table salt (sodium chloride) can activate immune cells and destroy cancer cells, discovers a new study. The findings of the study are published in...
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...
In a comprehensive review of recent genetic and population studies, published in the peer-reviewed medical journal Genomic Psychiatry (Genomic Press,...
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...
NEW ARTICLE: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel and kills Cancer Stem Cells! Ready to...